Gastrectomy is a surgical procedure which involves the removal of the entire stomach or parts of the stomach. Stomach is an integral part of our gastro-intestinal system with a primary function of breaking down the food into its components so that they can be subsequently absorbed by the small intestine. Radical Gastrectomy refers to the partial or complete removal of the gastric tissue along with the surrounding lymph nodes. This is often the only available curative treatment option in cases of stomach (gastric) cancers. Radical Gastrectomy is a major surgical procedure and this surgery is available abroad, in India, Mexico, Turkey, Jordan & South Korea, at lower rates and keeping in mind international quality.
Clinical evidence suggests that five year survival rate after radical gastrectomy, for patient with gastric carcinomas detected in the early stage is about 80% to 90%. However for late stages of the disease the prognosis is fairly poor and ranges from 30% to 40%. The main cause of death in this situation is attributed to recurrence due to metastasis in 50% of the cases.
The procedure is done under general anesthesia. Prior to undertaking the procedure, the following protocols are followed:
Most often conventional technique of radical gastrectomy is used, whereby a part or whole of the stomach is removed. The remaining part of the stomach is then connected to the small intestine so as to keep the gastrointestinal tract patent and allow passage of food material.
Laparoscopic gastrectomy has several advantages over the conventional procedure, namely:
However laparoscopic gastrectomy has a limited role in the management of gastric carcinomas. It can be used only for early stage gastric carcinoma and in cases where the intention is to palliate and alleviate pain rather than cure.
The Indian advantage includes low cost (one tenth of the prices in US), international quality with advanced technology, wide ranging and comprehensive specialized oncology services and one of the largest English speaking population in the world.
There are several centers and hospitals that have the JCI accreditation in the country which is the highlight of medical tourism. Its proximity to the United States gives it the added advantage over other destinations of medical tourism.
Spanning across both Europe and the Near East, Turkey has impacted the global medical tourism market considerably. It provides considerable cost advantage and with its future plans of joining the European Union, the government and local administration have enforced stringent and rigid quality norms making is the first grade medical tourism destination.
Jordan is focusing in a big way on medical tourism, which is estimated to be a $1 billion industry by 2010. With its focus on emerging as one of the hot spots for medical tourism in the Middle East, Jordan provides substantial advantage in terms of competitive cost and technology.
In 2008, South Korea received around 25,000 foreign medical tourists, which was a rise of more than 50% compared to the previous year. The country has specifically focused on the treatment and management of various kinds of cancers of the stomach and liver. This has given it an added advantage over other countries in management of malignancies and cancers.
Cyberknife in India
Cyberknife at Anadolu Medical Center, Turkey
Chemotherapy Treatment (CHOP) Abroad
Cyberknife Cancer Radiotherapy Overseas
Medical Tourism Corporation facilitates affordable Radical Gastrectomy Abroad in Europe (Turkey) and other overseas world-class oncology treatment destinations.
*Please review our full disclaimers, Terms & Conditions and, Health Privacy & Confidentiality Statement. Individual results may vary. The statements on this website have not been evaluated by the FDA or any medical professional.